ArticleFrontiers in oncology2025
Better performance of cerebral blood volume images synthesized from arterial spin labeling and standard MRI in separating glioblastoma recurrence from treatment response than arterial spin labeling.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral blood volume (CBV) maps play an important role in the differential diagnosis between glioblastoma recurrence and treatment response. However, it needs high injective velocity. This study aimed to synthesize CBV maps from arterial spin labeling (ASL) and standard MRI sequences using a deep learning method and to validate its discriminating value. A total of 744 MRI scans from 364 patients were included in this retrospective, single-institution study. A three-dimensional (3D) incrementable encoder-decoder network (IEDN) designed for an asymmetrical sample size was trained to synthesize the CBV maps from ASL and the standard MRIs. The synthetic performance was evaluated quantitatively using the structural similarity index (SSIM) and the peak signal-to-noise ratio (PSNR) and qualitatively using a four-point Likert scale (from 0 to 3). In 96 patients suspected of glioblastoma recurrence
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.